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Vasculitis
AbstrAct
Objectives to define the elementary ultrasound (US) 
lesions in giant cell arteritis (gca) and to evaluate the 
reliability of the assessment of US lesions according to 
these definitions in a web-based reliability exercise.
Methods Potential definitions of normal and abnormal 
US findings of temporal and extracranial large arteries 
were retrieved by a systematic literature review. as 
a subsequent step, a structured Delphi exercise was 
conducted involving an expert panel of the Outcome 
Measures in rheumatology (OMeract) US large Vessel 
Vasculitis group to agree definitions of normal US 
appearance and key elementary US lesions of vasculitis 
of temporal and extracranial large arteries. the reliability 
of these definitions on normal and abnormal blood 
vessels was tested on 150 still images and videos in a 
web-based reliability exercise.
Results twenty-four experts participated in both Delphi 
rounds. From originally 25 statements, nine definitions 
were obtained for normal appearance, vasculitis and 
arteriosclerosis of cranial and extracranial vessels. 
the ‘halo’ and ‘compression’ signs were the key US 
lesions in gca. the reliability of the definitions for 
normal temporal and axillary arteries, the ‘halo’ sign 
and the ‘compression’ sign was excellent with inter-
rater agreements of 91–99% and mean kappa values of 
0.83–0.98 for both inter-rater and intra-rater reliabilities 
of all 25 experts.
Conclusions the ‘halo’ and the ‘compression’ signs 
are regarded as the most important US abnormalities 
for gca. the inter-rater and intra-rater agreement of 
the new OMeract definitions for US lesions in gca was 
excellent.
InTROduCTIOn
Giant cell arteritis (GCA) is the most common 
primary systemic vasculitis, occurring 
predominantly in Caucasian populations.1 
Key messages
What is already known about this subject?
 ► Ultrasound (US) of temporal, axillary and other 
arteries is increasingly used for confirming a 
suspected diagnosis of giant cell arteritis (gca) in 
clinical practice.
 ► although several prospective studies comparing 
US with the clinical diagnosis and/or results of 
temporal artery biopsy reveal a good diagnostic 
performance, its diagnostic value has been 
questioned particularly because of a lack of data on 
reliability.
What does this study add?
 ► this study includes the first systemic literature 
review on US definitions of normal and abnormal 
temporal and extracranial arteries in suspected 
gca.
 ► this is the first study that provides definitions of the 
normal US appearance and key elementary lesions 
of vasculitis of temporal and extracranial large 
arteries based on international expert consensus.
 ► inter-rater and intra-rater reliabilities for reading 
stored US images and videos of normal and 
vasculitic temporal and axillar arteries applying the 
consensus-based definitions are excellent.
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GCA mainly involves large and medium-sized arteries, 
predominantly branches of the external carotid arteries 
such as the temporal arteries, and the aorta and its large 
branches such as the subclavian and axillary arteries. 
Temporal artery biopsy has been regarded as the gold 
standard for decades; however, biopsy is invasive, and it 
lacks sensitivity, particularly in extracranial large vessel 
(LV)-GCA.2 Imaging techniques including ultrasound 
(US), MRI and positron emission tomography-CT are 
increasingly being used in diagnosis of GCA and may in 
future replace biopsy in many cases.3 4 Notably, US is less 
invasive, reveals a higher sensitivity, particularly in extrac-
ranial disease, and results become available faster.5 Early 
diagnosis and treatment of patients with GCA are impor-
tant since patients may develop irreversible ischaemic 
complications, including vision loss and stroke. The 
implementation of fast track clinics that involve US as 
a point-of-care test for patients with suspected GCA has 
led to a decrease of permanent vision loss.6 7 A recently 
published multicentre study showed that a diagnostic 
algorithm including US is cost-effective compared with a 
conventional strategy focusing on biopsy only.2
GCA is characterised by inflammatory infiltration of 
the artery wall resulting in the so-called ‘halo’ sign, first 
described in 1995, which is a hypoechoic (dark) thick-
ening of the vessel wall as visualised by US.8 In contrast 
to the healthy artery, the inflammatory wall thickening 
is not compressible upon application of pressure with 
the US probe. This feature has recently been termed the 
‘compression’ sign.9
Several studies have been conducted thus far to inves-
tigate the accuracy, construct and criterion validity of 
US in the diagnosis of GCA, and four meta-analyses 
of these studies have been published until now.10–13 
Despite the growing body of evidence supporting the 
utility of US in GCA, standardised definitions of the 
elementary normal and abnormal appearance and 
their reliability are lacking. Therefore, an Outcome 
Measures in Rheumatology (OMERACT) Large Vessel 
Vasculitis (LVV)-US Working Group was formed in 
order to agree on the US lesions suggestive of GCA as 
well as to test the reliability of these definitions.
The first aim of this study was to retrieve currently avail-
able definitions of US key elementary lesions describing 
vasculitis in temporal and extracranial large arteries by a 
systematic literature review (SLR). Second, we intended 
to produce consensus-based definitions of normal and 
GCA characteristic appearances of temporal and extra-
cranial large arteries as detected by US, using a Delphi 
process among international experts. This Delphi process 
included definitions of the US appearance of (1) normal, 
(2) arteriosclerotic and (3) vasculitic temporal and axil-
lary arteries and (4) a consensus on which anatomical 
structures and findings should be considered when 
performing US in suspected GCA. The third aim was 
to test the inter-rater and intra-rater reliabilities of the 
definitions of each elementary US lesion in GCA using a 
web-based exercise.
MeThOds
study design
The study design followed the stipulated OMERACT 
methodology in accordance with previous studies of 
the OMERACT US Working Group for defining disease 
Figure 1 Normal temporal artery branch: (A) longitudinal view; (B) transverse view; (C) longitudinal view before compression; 
(D) longitudinal view with compression; (E) transverse view before compression and (F) transverse view with compression. The 
arrows are indicating the artery.
How might this impact on clinical practice?
 ► these consensus-based definitions provide clinicians with a clear 
guideline on how to evaluate US findings in suspected gca.
 ► they provide a basis for future trials in gca including US as an 
inclusion criterion and evaluating US as an outcome parameter.
 ► this study shows that images and videos of US examinations of 
temporal and axillary arteries in suspected gca can be stored and 
reliably re-evaluated by experts.
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characteristic lesions and testing reliability of US in other 
rheumatic diseases.14–16 The OMERACT LVV-US Working 
Group was formed at the Annual American College of 
Rheumatology (ACR) meeting Boston, Massachusetts, 
USA, in 2014.
sLR to identify previously applied us definitions of LVV
According to the OMERACT standard operating 
procedures, a SLR was conducted to identify defini-
tions of normal and abnormal US appearance of large 
arteries applied in previous studies. Details on the key 
question, search, data synthesis and quality assessment 
are provided in the online supplementary material. 
In brief, two authors (CDu and CDe) searched the 
PubMed, EMBASE and the Cochrane Library data-
bases using Medical Subject Headings (MeSH) terms, 
full text and truncated words (see online supplemen-
tary material for full search strategy) from the incep-
tion dates (1946, 1974 and 1993, respectively) to 23 
November 2014. The following inclusion criteria 
were applied: (1) number of patients enrolled ≥20 
patients and (2a) full research articles of prospective 
or retrospective studies on diagnostic accuracy of US 
in suspected LVV (ie, cranial and extracranial LV-GCA, 
Takayasu arteritis (TAK) and idiopathic aortitis as these 
exhibit similar US pathologies) using an appropriate 
reference standard (ie, clinical diagnosis, published 
criteria and/or positive temporal artery biopsy) or 
(2b) cross-sectional studies assessing LVV by US in 
patients with established GCA, polymyalgia rheumatica 
(PMR) or TAK. Data were extracted using a predefined 
template. The Quality Assessment of Diagnostic Accu-
racy Studies-2 and Quality In Prognosis Studies tools 
were used to assess quality of diagnostic accuracy and 
prognostic studies, respectively17 18 (see online supple-
mentary tables S4 and S6).
delphi consensus on definitions of LVV elementary us 
appearances
The group decided to focus the Delphi exercise on US 
key lesions for GCA only, because of the paucity of US 
data in TAK and idiopathic aortitis.
Figure 2 Abnormal temporal artery branch: (A) longitudinal view with ‘halo’ sign; (B) transverse view with ‘halo’ sign; (C) 
longitudinal view before compression; (D) longitudinal view with compression (‘compression’ sign positive); (E) transverse view 
without compression and (F) transverse view with compression (‘compression’ sign positive).
Figure 3 Axillary artery: (A) longitudinal view of normal artery; (B) transverse view of normal artery; (C) longitudinal view with 
‘halo’ sign and (D) transverse view with ‘halo’ sign.
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Based on the results from the SLR, the steering 
committee (CDu, CDe and WAS) developed a WORDTM-
based written questionnaire that included 25 statements. 
Of these 25 statements, 3 addressed the definitions of 
the appearances of normal and arteriosclerotic temporal 
and extracranial large arteries; 15 statements addressed 
5 definitions of the ‘halo’ sign, stenosis (temporal and 
extracranial large arteries), occlusion, ‘compression’ sign 
(temporal arteries) and vessel wall pulsation (temporal 
arteries) and 7 statements addressed the requirements 
for diagnosis of vasculitis by US.
Twenty-five physicians experienced in US and/or LVV 
were invited by email to participate. They were from 14 
countries (Austria, Czech Republic, Denmark, France, 
Germany, Italy, Norway, Poland, Portugal, Slovenia, Spain, 
The Netherlands, UK and USA). The group consisted of 
22 rheumatologists, 1 internist and 2 physicians in the 
last year of rheumatology training. Nine, six, four, two 
and four participants have performed >300, 101–300, 
51–100, 21–50 and <20 diagnostic GCA US examinations, 
respectively. Sixteen were currently offering a diagnostic 
GCA US clinic. The participants were asked to rate each 
definition using a level of agreement or disagreement 
for each statement according to a 1–5 Likert scale with 
1=strongly disagree, 2=disagree, 3=neither agree nor 
disagree, 4=agree and 5=strongly agree. A Likert score of 4 
or 5 was considered as agreement. Only when statements 
achieved a score of >75%, a consensus was considered for 
appropriately defining the category. Statements satisfying 
these requirements were used for the definition of the 
most important US elementary appearances for the diag-
nosis of vasculitis. Those statements with already achieved 
agreement, but suggestions for an improved wording in 
the first Delphi round were rephrased according to the 
experts’ comments and reappraised in the second round. 
Statements with a <75% agreement in the first round 
were not further taken to the second round.
The questionnaire also included a rating of the impor-
tance of the different US elementary appearances for the 
diagnosis of cranial and extracranial LVV using a Likert 
scale as mentioned above. Up to two reminders were sent 
out to the experts if they had not responded within the 
given time limit. The answers of the first Delphi round 
were summarised with the percentage of agreement 
to each statement. For the second Delphi round, all 
comments of the panelists were anonymised and re-sent 
together with a questionnaire revised by the steering 
committee to those experts who had responded in the 
first round. At a face-to-face meeting of the expert panel 
(‘round 3´), held at the 2015 San Francisco ACR Meeting, 
the wording of one definition was slightly revised.
Inter-rater and intra-rater web-based reliability exercise
All members of the OMERACT LVV-US Working Group 
were asked to submit 16 representative still images 
and 20 representative videos (figures 1-3): eight still 
images and eight videos represented normal anatomical 
segments (common temporal artery, frontal branch, 
parietal branch and axillar arteries) in longitudinal and 
transverse planes; and the eight other still images and 
eight videos represented the same segments exhibiting 
the ‘halo’ sign. Four additional videos showed a positive 
and a negative ‘compression’ sign of the temporal artery 
branches in longitudinal and transverse views, respec-
tively. All pathological images and videos originated 
from patients with active disease who met the expanded 
ACR classification criteria of GCA, and in whom diag-
nosis was confirmed either by temporal artery biopsy or 
on a clinical basis, including US and follow-up.19 The 
images and videos were collected by a facilitator of the 
group (SC) who constructed an electronic database 
using REDCap (Research Electronic Data Capture; 
Vanderbilt University, Nashville, Tennessee, USA) 
hosted by a server from the Italian Society for Rheuma-
tology.20
From 550 submitted images and videos, 150 images and 
videos were selected by the facilitator for the web-based 
reliability exercise: 20 videos of axillary arteries, 20 still 
images of axillary arteries, 45 videos of temporal arteries, 
45 still images of temporal arteries and 20 videos of the 
‘compression’ sign applied to temporal arteries. The 
distribution between longitudinal/transverse views and 
normal/pathological vessels was as follows: temporal 
artery still images and videos: transverse 56, longitudinal 
54, pathological 57 and normal 53. Axillary artery still 
images and videos: transverse 18, longitudinal 22, patho-
logical 19 and normal 21. A link with the web-based exer-
cise was sent to the same physicians who participated in 
the Delphi process, asking them to apply the definitions 
agreed in the Delphi exercise to decide whether each 
still image or video was suggestive of vasculitis according 
to the definitions. Two weeks after the first evaluation, 
the participants received the same images and videos in a 
different order for evaluating the intra-rater agreement.
All images and videos were anonymised for patients’ 
data, the centre where the image was obtained, US 
machine settings/producer and intima-media thickness 
(IMT) measurements. Images and videos from patients 
were only submitted from countries without restrictions 
for patient image transfer.
statistical analysis
In the SLR and in the Delphi process, only descriptive 
statistics were used. Intra-rater and inter-rater reliabil-
ities were calculated using the kappa coefficient (κ). 
Intra-rater reliability was assessed by Cohen’s κ, and 
inter-rater reliability was studied by calculating the mean 
κ on all pairs (ie, Light’s κ).21 Kappa coefficients were 
interpreted according to Landis and Koch with κ values 
of 0–0.2 considered poor, 0.2–0.4 fair, 0.4–0.6 moderate, 
0.6–0.8 good and 0.8–1 excellent.22 The percentage 
of observed agreement (ie, the percentage of observa-
tions that obtained the same score) and prevalence of 
the observed lesions were also calculated. Analyses were 
performed using R Statistical Software (Foundation for 
Statistical Computing, Vienna, Austria).
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ResuLTs
sLR on definitions of key elementary us lesions describing 
vasculitis
Out of 2960 articles screened, 39 studies were finally 
included (see online supplementary figure S1). Some 
of these studies addressed more than one key objective 
(and are reported in the following as if they were sepa-
rate articles). Twenty-four articles focused on diagnostic 
accuracy of US in GCA9 23–45 (main study characteristics, 
detailed results including risk of bias and provided defi-
nitions of US key elementary lesions are summarised in 
online supplementary tables S2–4), studies investigated 
the value of US for the prediction of GCA outcome46–48 
(online supplementary tables S5–6), 13 studies 
reported the possible role of US for monitoring disease 
activity23 27 28 30 33 36 37 39 40 46–49 (online supplementary 
table S7) and 14 cross-sectional studies assessed LVV by 
US in patients with GCA, PMR and TAK4 30 37 49–59 (online 
supplementary table S8). All diagnostic accuracy studies 
evaluated the role of US for the diagnosis of cranial GCA, 
two of them also included patients with extra cranial 
LV-GCA.37 44 In seven reports, arterial involvement of 
patients with PMR was addressed,23 27 36 50–53 and two 
cross-sectional studies assessed by US the involvement of 
LV in patients with TAK.58 59 No diagnostic accuracy study 
was identified for TAK and isolated idiopathic aortitis.
Most US studies in patients with GCA and PMR tested 
the ‘halo’ sign (n=36)4 9 23–44 46–57 as a key elementary 
lesion defining vasculitis. Other US signs of vascu-
litis reported (mostly in combination with the ‘halo’ 
sign) were stenosis (n=21),4 9 23–25 30 32 33 36–38 41 46 49–56 
occlusion (n=18),4 9 23 30–32 36 38 41 46 49–56 the ‘compres-
sion’ sign (n=2)9 45 and a conspicuous vessel wall pulsa-
tion by M-mode (n=1).31 Cut-off values of the IMT for 
the definition of the ‘halo’ sign were provided in nine 
studies,4 27 38 39 43 50 53 54 57 ranging from 0.3 to 1 mm for 
temporal arteries and from 1.3 to 2 mm for extracranial 
large arteries. For TAK, the term ‘Macaroni ‘sign has been 
used in two studies describing the same pathology as the 
‘halo’ sign.58 59 Stenosis, occlusion and arterial dilatation 
have also been addressed as US key elementary signs in 
patients with TAK.58 59
No separate definitions for the distinction between 
acute and chronic vasculitic lesions have been published, 
neither for GCA nor for TAK.
delphi exercise
Twenty-four of the 25 invited participants responded to 
the first Delphi questionnaire (96% response rate). All 
24 participants also responded to the second round of 
the Delphi questionnaire (100% response rate).
In round 1, a consensus was achieved on nine defini-
tions on normal temporal and extracranial large arteries, 
arteriosclerosis, ‘halo’ sign, stenosis of temporal and 
extracranial large arteries, occlusion, ‘compression’ sign 
(temporal arteries) and US assessment of the ‘compres-
sion’ sign (temporal arteries) (table 1). A definition of 
the ‘halo’ sign not including the measurement of the 
IMT was preferred by the group, because of the high vari-
ance of proposed cut-off values for temporal and extra-
cranial large arteries found in the SLR and the lack of 
validated data at that time.4 27 38 39 43 50 53 54 57
In round 2, three definitions (arteriosclerosis, ‘halo’ 
sign and stenosis of temporal arteries) were redefined, 
voted and agreed upon. The statements on vessel wall 
pulsation (definition and assessment) and the assessment 
of the ‘halo’ sign by measurement of vessel wall thick-
ness did not reach the threshold for consensus. At the 
OMERACT LVV-US face-to-face group meeting (‘round 
3’), the second part of the definition on ´stenosis in 
temporal arteries´ was rephrased from ‘… before or 
behind the stenosis’ to ‘… proximal or distal to the 
stenosis’. The final definitions for normal and patho-
logical cranial and extracranial vessels are described in 
table 1.
The ‘halo’ sign and ‘compression’ signs were deemed 
to be the most important US signs for cranial and extra-
cranial GCA with 100% and 83.3% agreement, respec-
tively. Of the panelists, 95.8 % thought that the ‘halo’ 
sign needs to be present to meet the minimum require-
ment for vasculitis.
Web-based exercise on still images and videos
Eighteen members from 13 different countries had 
submitted images and videos including five different US 
brands (Hitachi, Esaote, GE, Siemens and Philips) using 
linear transducers with maximum grey scale frequencies 
of 15, 18 or 22 MHz. Twenty-five group members partic-
ipated in the web-based exercise in round 1, and 25/25 
participants (100%) performed the exercise in round 2.
The reliability of the 25 participants was excellent 
with mean inter-rater agreements for all still images and 
videos of 91–99% and mean Light’s κ values of 0.83–0.98 
for inter-rater reliability (table 2) depending on the 
lesions and sites assessed. Also, the examined intra-rater 
reliability with a mean agreement of 91–99% and a mean 
Cohen`s kappa values of range 0.83–0.98 (table 3) was 
excellent. The inter-rater and intra-rater reliabilities 
performed all with κ >0.8 irrespective of the view (longi-
tudinal or transverse, still images or videos) or anatom-
ical segments.
dIsCussIOn
Many previous studies have investigated US as a diag-
nostic tool for GCA using different definitions for normal 
and abnormal findings. This study now provides expert 
consensus-based definitions for US in LVV that can be 
applied in future studies. The consensus-based defini-
tions revealed excellent inter-rater and intra-rater relia-
bilities when tested on images and videos of patients.
Although we included all types of LVV as possible 
search terms in the SLR, the Delphi as well as reliability 
exercise was focused on GCA only, as the SLR revealed 
insufficient data to provide a solid basis for the consensus 
process. It is, however, the clinical experience of the 
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Table 1 Statements on definitions (n=8) and conduction (n=1) of ultrasound (US) elementary appearances in large vessel 
vasculitis agreed upon through a Delphi survey
Domain Definition
Agreement 
(%)
Delphi 
round
US appearance of
  normal temporal 
arteries
Pulsating, compressible artery with anechoic lumen surrounded by mid-echoic to 
hyperechoic* tissue. Using US equipment with high resolution, the intima-media 
complex presenting as a homogenous, hypoechoic or anechoic echostructure 
delineated by two parallel hyperechoic margins (‘double line pattern’) may be 
visible.
95.7 1
  normal 
extracranial large 
arteries
Pulsating, hardly compressible artery with anechoic lumen; the intima-media 
complex presents as a homogenous, hypoechoic or anechoic echostructure 
delineated by two parallel hyperechoic margins (‘double line pattern’), which is 
surrounded by mid-echoic to hyperechoic tissue.
100 1
  arteriosclerotic 
arteries
Heterogeneous and in part hyperechoic, irregularly delineated and eccentric 
vessel wall alteration.
95.8 2
  ‘halo’ sign Homogenous, hypoechoic wall thickening, well delineated towards the luminal 
side, visible both in longitudinal and transverse planes, most commonly 
concentric in transverse scans.
91.3 2
  stenosis in 
temporal arteries
A stenosis is characterised by aliasing and persistent diastolic flow by colour 
Doppler US. The maximum systolic flow velocity determined within the stenosis 
by pulsed wave-Doppler US is ≥2 times higher than the flow velocity proximal or 
distal to the stenosis.
95.8
100
2
3
  stenosis in 
extracranial large 
arteries
Typical vasculitic vessel wall thickening with characteristic Doppler curves 
showing turbulence and increased systolic and diastolic blood flow velocities.
75 1
  occlusion Absence of colour Doppler signals in a visible artery filled with hypoechoic 
material, even with low pulse repetition frequency and high colour gain.
87.5 1
  ‘compression’ 
sign of temporal 
arteries
The thickened arterial wall remains visible upon compression; the hypoechogenic 
vasculitic vessel wall thickening contrasts with the mid-echogenic to 
hyperechogenic surrounding tissue.
78.3 1
US assessment of
  ‘compression’ 
sign of temporal 
arteries
The compression sign should be assessed by applying pressure via the 
transducer until the lumen of the temporal artery occludes and no arterial 
pulsation remains visible.
91.3 1
*The term ‘midechoic’ is equivalent to the term ‘isoechoic’.
Table 2 Inter-rater agreements for the ‘halo’ and ‘compression’ signs in temporal and axillary arteries
Section
Lesion (mean 
prevalence, %)*
Agreement 
(mean, %)
Agreement
(range)
Light‘s κ 
(mean)
Light‘s κ 
(range)
‘halo’ (all images & videos) 51.4 94 82–100 0.89 0.65–1
‘halo’ (all images) 54 98 89–100 0.95 0.78–1
‘halo’ (all videos) 49.3 92 77–100 0.84 0.54–1
‘halo’ temporal arteries (images & videos) 53.2 94 78–100 0.87 0.58–1
‘halo’ temporal arteries (images) 57.5 97 84–100 0.94 0.69–1
‘halo’ temporal arteries (videos) 50 91 74–100 0.83 0.49–1
‘halo’ axillary arteries (images & videos) 46 97 80–100 0.93 0.58–1
‘halo’ axillary arteries (images) 45 99 90–100 0.98 0.80–1
‘halo’ axillary arteries (videos) 47 94 70–100 0.88 0.34–1
‘compression’ sign (videos) 53.6 92 70–100 0.83 0.34–1
*Calculated as pathological lesions out of 100 presented images and/or videos.
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experts that US abnormalities in patients with TAK look 
similar. Future US studies in TAK and idiopathic aortitis 
are necessary to gather more data on US key lesions also 
in these LVV entities.
The OMERACT Group agreed that ‘halo’ sign and 
‘compression’ sign should be regarded as the primary 
elementary US signs of cranial and/or LV-GCA without 
including stenosis or occlusion. The ‘halo’ sign has 
been applied in most published studies.4 9 23–44 46–57 The 
‘compression’ sign was only addressed by two studies from 
one research group so far.9 45 However, it has shown good 
diagnostic performance and is feasible in daily practice. 
It is a method to better visualise the ‘halo’ sign. In early 
studies, the presence of stenosis helped to increase the 
sensitivity of temporal artery US.10 23 On the other hand, 
many sonographers feel that stenosis may reduce the 
specificity of the examination.2 Furthermore, due to far 
higher resolution of modern US equipment, a ‘halo’ sign 
can now usually be visualised in stenotic vessel areas, and 
temporal artery occlusions in GCA usually occur together 
with the non-compressible ‘halo’ sign’.5
It was also agreed not to include the measurement of 
IMT for the definition of the ‘halo’ sign, as at the time 
of the Delphi process only proposals for cut-off values 
but no studies for validating cut-off values were available. 
Several previous studies had proposed a wide range of 
cut-off values for the diameter of a halo sign, for example, 
0.3–1 mm for temporal arteries and 1.3–2 mm for extra-
cranial large arteries.4 27 38 39 43 50 53 54 57 A study investigating 
patients with newly diagnosed active GCA and healthy 
controls has been recently performed by members of the 
group (WAS and VSS) for calculating IMT cut-off values 
in normal temporal and axillary arteries.60 The role of 
IMT measurements for diagnosis and monitoring is yet 
uncertain and needs to be addressed by future studies.
The inter-rater and intra-rater agreements of the 
web-based exercise were excellent. Images and videos 
were submitted by participating experts as in previous 
OMERACT-related US exercises.14–16 61 Images and videos 
for the present web-based exercise were taken from 
patients with newly diagnosed active GCA since US signs 
in patients with established disease resolve rapidly with 
treatment.40 Reliability data for 12 sonographers reading 
videos from the international multicentre TABUL study 
have now been published.2 Videos from that study were 
randomly chosen from all stored videos of the study, irre-
spective of their quality, whereas the quality of images 
and videos in the OMERACT study may have been better 
as the members submitted material which they deemed 
representative. Sonographers of the TABUL study were 
less experienced than sonographers of the present 
OMERACT study. Kappa values for the intra-rater reli-
ability in the TABUL study were 0.69–0.81. Inter-rater 
reliability was only provided as intraclass correlation coef-
ficients (ICCs). Notably, the reliability of 14 pathologists 
reading temporal artery biopsy specimens was similar 
when compared with the 12 sonographers (ICC 0.61 vs 
0.62).
We asked the experts to submit images from GCA 
cases and controls which include patients with arterio-
sclerosis. Few of the control cases indeed had arterioscle-
rotic changes; however, we did not specifically question 
in our rating to distinguish between arteriosclerosis and 
non-arteriosclerotic controls. We were therefore unable 
to conduct a separate analysis in this regard. We did not 
score images and videos with stenosis or occlusions.
In conclusion, an international expert consensus was 
reached using OMERACT methodology for the defi-
nitions of normal US appearance and abnormalities 
seen in the temporal and axillary arteries in GCA. This 
OMERACT exercise (along with the previously reported 
TABUL study) shows that images and videos of US scans 
of inflamed temporal and axillary arteries can reliably 
document the characteristic and diagnostic abnormali-
ties in patients with suspected GCA. Our study supports 
the use of US abnormalities, including both images and 
videos, as an inclusion criterion for future GCA trials. 
Confidence is increasing in the use of US in mainstream 
clinical practice, and it may be incorporated into future 
guidelines for GCA diagnosis.
Table 3 Intra-rater agreements for the halo’ and ‘compression’ signs in temporal and axillary arteries
Section
Lesion
(mean prevalence, 
%)
Agreement 
(mean, %)
Agreement
(range)
Cohen´s κ 
(mean)
Cohen´s κ 
(range)
‘halo’ (all images & videos) 51.4 95 83–99 0.89 0.66–0.99
‘halo’ (images) 54 98 89–100 0.96 0.79–1
‘halo’ (videos) 49.4 92 79–100 0.84 0.56–1
‘halo’ temporal arteries (images & videos) 53.3 94 83–99 0.88 0.66–0.98
‘halo’ temporal arteries (images) 57.9 97 89–100 0.94 0.78–1
‘halo’ temporal arteries (videos) 50.1 91 78–100 0.83 0.57–1
‘halo’ axillary arteries (images & videos) 46 96 78–100 0.93 0.53–1
‘halo’ axillary arteries (images) 45 99 90–100 0.98 0.80–1
‘halo’ axillary arteries (videos) 47.1 94 65–100 0.87 0.21–1
‘compression’ sign (videos) 53.3 91 75–100 0.83 0.48–1
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The next step in the OMERACT validation process is 
the inter-rater and intra-rater reliability test of these defi-
nitions for normal and vasculitic arteries in patient-based 
exercises.
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